Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.05 USD
Change Today +0.01 / 0.96%
Volume 11.5K
DCTH On Other Exchanges
DCTH is not on other exchanges.
As of 1:58 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jennifer K. Simpson Ph.D., M.S.N., C.R.N.P.

Interim Chief Executive Officer, Interim President, Executive Vice President and Global Head of Business Operations, Delcath Systems, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Dr. Jennifer K. Simpson has been an Interim Chief Executive Officer and Interim President of Delcath Systems, Inc. since September 13, 2014. Dr. Simpson has been the Global Head of Business Operations and Executive Vice President of Delcath Systems, Inc. since April 8, 2013. Dr. Simpson has responsibility for global sales, marketing, regulatory, quality, clinical development, and medical affairs activities. Dr. Simpson served as an Executive Vice President of Global ...

Read Full Background

Corporate Headquarters*

1301 Avenue of the Americas
New York, New York 10019

United States

Phone: 212-489-2100
Fax: 212-489-2102

Board Members Memberships*

There is no Board Members Memberships data available.


The City University of New York
University of Pittsburgh
University of Rochester

Other Affiliations*

Annual Compensation*

Total Annual Compensation$309,572

Stock Options*

All Other Compensation$21,789
Exercisable Options1,250
Unexercisable Options16,624
Total Number of Options17,874

Total Compensation*

Total Annual Cash Compensation$331,361
Total Short Term Compensation$309,572
Other Long Term Compensation$21,789
Total Calculated Compensation$417,255
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DCTH:US $1.05 USD +0.01


James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
Gilman E. Wong Chief Executive Officer, Managing Director and Executive Director
Sirtex Medical Limited
Joseph M. Devivo Chief Executive Officer, President and Director
AngioDynamics Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DELCATH SYSTEMS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at